Regent’s Park appoints a Director of Corporate Development

LONDON, United Kingdom, 14 September, 2009: Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced it has appointed Daniel Oberholzer as its Director of Corporate Development.

Prior to joining Regent’s Park, Daniel worked in a variety of commercial and financial roles for HCA hospitals, the largest group of private hospitals in London and for Medical Diagnostic and Imaging, a leading provider of diagnostic and imaging services in the UK. Daniel has attained a wealth of experience in the independent cardiovascular healthcare sector, which includes experience in working with the NHS on various projects.

Daniel is well experienced in defining business system requirements, designing and delivering of solutions, as well as the implementation of consistent operational processes. He has a passion for creating high quality, value based organisations. Daniel’s responsibilities include strategy, business development and operations.

“Daniel has a strong track record of being able to help patient-focused healthcare companies grow, and I’m excited that he will bring that insight to our company,” said CEO & Chairman, Dr. Ohri. “He possesses strategic skills, leadership traits and a wealth of operational, financial, and corporate development experience that will be a tremendous benefit.”

Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 22,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

DOWNLOAD PRESS RELEASE

Regent’s Park to open the ‘Cambridge Heart Clinic’

LONDON, United Kingdom, 4 July, 2008: Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced it has entered into a partnership to develop a specialist heart clinic on the grounds of Addenbrooke’s Hospital in Cambridge.

The partnership will lead to the development of a dedicated private patient cardiology centre within Addenbrooke’s Hospital, to be called “The Cambridge Heart Clinic”. The heart clinic will be operated by Regent’s Park and will initially provide a comprehensive range of outpatient based investigations such as screening, electrocardiography, echocardiography and stress tests, as well as invasive cardiac procedures such as angiography and pacemaker insertion. Over time the heart clinic will migrate to providing percutaneous coronary intervention and cardiac electrophysiology services.

“We are extremely pleased to be entering this long-term partnership with the world-famous Addenbrooke’s Hospital,” says Dr. Ohri, Chief Executive Officer of Regent’s Park. “This reflects our largest venture with an NHS Trust since we announced our intention to partner with NHS providers to make our cardiovascular expertise available in a host of different partnership arrangements. It is the first of a series of heart clinics in our development pipeline, and is therefore an important step forward for Regent’s Park.”

He added, “we are particularly excited about working more closely with Addenbrooke’s cardiologists and the Trust to help bring their experience and expertise to assist us in implementing clinical improvements, marketing initiatives and operating efficiencies. It will mean that private patients are assured of a first-class patient experience in a safe, high-quality environment. It also means that the Trust can re-invest surplus monies back into NHS patient care. We view this type of arrangement as important to our joint success.”

The Cambridge Heart Clinic is scheduled to open in late October 2008.
Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 12,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

DOWNLOAD PRESS RELEASE

100% service uptime record at Addenbrooke’s Hospital

Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced an unprecedented 100% service uptime over the duration of its contract to provide mobile cath lab services at Addenbrooke’s Hospital in Cambridge. Addenbrooke’s Hospital is part of Cambridge University Hospitals NHS Foundation Trust. Addenbrooke’s is the teaching hospital for the University of Cambridge with a reputation for clinical excellence both nationally and internationally.

Dr. Michael O’Sullivan, Director of Cardiology & Consultant Cardiologist at Addenbrooke’s Hospital said “Regent’s Park have provided an excellent service to our Trust over the last two years. There has been a 100% service uptime record with not a single cancellation of a catheter lab session. Our patients have benefited enormously with a large reduction in inpatient waiting times for cardiac catheterisation procedures.”

Dr. O’Sullivan added: “Everyone in our Trust has been extremely impressed and we would have no hesitation in recommending their services to other NHS hospitals. The service has allowed our Trust with the perfect way to expand its invasive cardiology services and Regent’s Park have also helped us to develop our fixed site catheter lab services that will be opening shortly. We expect them to be our long term cardiology partners and I am sure more news on this exciting partnership will follow shortly from both parties.”

Dr. Ohri, Chief Executive of Regent’s Park, said, “It has been a tremendous privilege to work alongside the committed and highly skilled cardiologists and staff at Addenbrooke’s Hospital. We always set ourselves high quality hurdles at Regent’s Park and we are very proud of our 100% service record at Addenbrooke’s. I believe this has been achieved for three main reasons – our strategy of providing brand new cath labs, good operations management and most importantly, the professionalism and teamwork of NHS and Regent’s Park staff.”

Dr. Ohri added: “I would like to use this opportunity to pay a special tribute to the following Regent’s Park staff who through their dedication have made this partnership so successful over the last two years:

  • Radiographers: Andrew White, Elizabeth Wishart, Ian Court & Bruce Atkins;
  • Cardiac Physiologists: Kenny Treacher & Michael Octave; and
  • Cardiac Nurses: Bryn Webber, Natalie Quinnell, Mo Mesad & Sue Ansell.”

Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 10,000 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

DOWNLOAD PRESS RELEASE

Second Cardiac Electrophysiology Laboratory Open in Oxford

Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced it opened a second state-of-the-art cardiac electrophysiology (“EP”) and ablation laboratory at The John Radcliffe Hospital in Oxford. The John Radcliffe is a major tertiary cardiothoracic teaching centre providing open-heart surgery and leading-edge cardiology with strong academic links with the medical sciences faculty of Oxford University.

The EP lab was officially opened by Trevor Campbell-Davis, Chief Executive of the Oxford Radcliffe Hospitals NHS Trust and Dr. Stephen Green, Consultant to the Department of Health vascular programme.

Trevor Campbell Davies, Chief Executive, Oxford Radcliffe Hospitals NHS Trust said: “We are pleased to be working with Regent’s Park and thank them for providing us with the ability to expand our capacity during the transition period between the expansion and upgrade of services that is currently underway on the John Radcliffe site.”

Dr. Ohri added: “The delivery of this bespoke lab in just 12 weeks and on budget was achieved through a close working collaborative with the Trust. To our knowledge, we are the only company in the UK or Europe to have developed these type of specialist cardiac arrhythmia laboratories. The inspiration for their development followed an invitation I received to visit the Cleveland Heart Clinic about a year ago. The Cleveland Heart Clinic is considered to be one of the best heart centres in the world, and seeing first hand the size, versatility and technology-driven nature of their cath labs, made me realise the need for us to embrace international best practice and to follow a similar course”.

Bryn Webber, Lead Nurse at Regent’s Park, commented: “Visitors to this lab are surprised by both the amount and the use of the space we have been able to provide within a modular environment. Having worked in and visited many catheter lab facilities across the UK, I really appreciate the importance of the working area and its impact on operational flow and patient saftey. In many ways I feel this modular facility outperforms a number of fixed site catheter labs for its space, layout and clinician friendly feel. For once it feels as though a catheter lab has been built to focus on the needs of catheter lab staff and the patients they serve”.

Dr. Ohri said: “Regent’s Park have taken the strategic decision to invest in the cardiac arrhythmia services marketplace across the UK and have a series of additional specialist EP catheter labs in the pipeline. However, we realise that developing improved working environments for the electrophysiology community is not enough, and that we will also need to focus our efforts on addressing the chronic shortage of appropriately trained EP cardiac physiologists and arrhythmia nurses. We intend to respond to this shortage by putting in place innovative recruitment, training and retention strategies over the coming months and years”.

Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. The company was founded in 2002 to pioneer joint ventures with the NHS across the field of cardiac services, delivering expertise, quality and innovation in one value for money package.

Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

Its guiding philosophy is that every patient with heart disease should have access to healthcare of a worldclass standard.

Dr. Ohri, Chief Executive, Regent’s Park Heart Clinics responded: “Regent’s Park are very proud to have worked with the Trust since 2004, and were delighted to have been asked to expand EP service provision. This second EP lab is the most modern and advanced in our fleet, and its deployment reflects both the continuing growth within the cardiac arrhythmia services marketplace as well as the excellent relationship we have developed with the Trust.

The cath lab was delivered in three sections, using a super-size 121 metre high crane weighing 500 tonnes, before being lowered into a small quadrant within the John Radcliffe Hospital beside the Cardiac Investigations Annexe.

DOWNLOAD PRESS RELEASE

Award of a contract at Addenbrooke’s Hospital, Cambridge

Regent’s Park Heart Clinics Ltd. (Regent’s Park), an independent healthcare company specialising in the diagnosis and treatment of heart disease, today announced it has been awarded a long-term contract to provide invasive cardiology services at Addenbrooke’s Hospital in Cambridge. Addenbrooke’s Hospital is part of Cambridge University Hospitals NHS Foundation Trust. Addenbrooke’s is the teaching hospital for the University of Cambridge, a centre for specialist services, and a leader in research and development.

Dr. Ohri, Chief Executive of Regent’s Park said: “Winning this fiercely competitive tender is terrific news for our company. The success helps develop our nationwide distribution network of healthcare services and confirms our position as the UK’s leading managed cardiology services provider. The award also fits extremely well with our strategy to forge links with leading University Teaching Hospitals from across the NHS. Addenbrooke’s has a formidable reputation as a world-class centre of excellence in biomedical sciences and it will be a huge privilege for our staff and organisation to be working alongside this great institution.”

Dr. Ohri added: “We will be providing Cambridge with one of our highly-bespoke cardiac SuperLabsTM. The Cambridge SuperLabTM will be equipped with a brand new Siemens Artis dFC Cardiology System – This is state-of-the-art flat plate detector technology designed to improve the visualisation of detailed coronary anatomy. It will allow heart disease in our patients to be detected and managed more easily.”

Cambridge University Hospitals NHS Foundation Trust has an income of over £360 million and around 1100 beds, it employs over 6500 staff dedicated to the provision of a wide range of clinical and non-clinical services. The Trust is a leading international centre for biomedical research and medical education, and shares its site with the University of Cambridge, the Medical Research Council, the Wellcome Trust, the British Heart Foundation and Glaxo SmithKline. Addenbrooke’s is a national and regional centre for cancer services, liver transplants, organ transplantation, neurosciences and genetics.

Regent’s Park is an independent company dedicated to creating world-class centres for the diagnosis and treatment of heart disease. The company develops, owns and operates diagnostic and treatment facilities focusing exclusively on cardiovascular disease in partnership with leading hospitals and groups of cardiologists across the United Kingdom. Regent’s Park has been a national provider of cardiology services to the NHS since 2003, and has provided invasive cardiology procedures to over 8,500 patients through its facilities – coronary angiograms, coronary angioplasty, cardiac electrophysiology, defibrillator and pacing procedures. Regent’s Park prides itself on its ability to deliver high quality, cost effective cardiac care, through excellent service, efficient operations management, well trained staff, and uncompromising professionalism.

The Regent’s Park guiding philosophy is that every patient with heart disease should have access to healthcare of a world-class standard.

DOWNLOAD PRESS RELEASE